65 related articles for article (PubMed ID: 17266040)
21. Optimal excitation wavelengths for in vivo detection of oral neoplasia using fluorescence spectroscopy.
Heintzelman DL; Utzinger U; Fuchs H; Zuluaga A; Gossage K; Gillenwater AM; Jacob R; Kemp B; Richards-Kortum RR
Photochem Photobiol; 2000 Jul; 72(1):103-13. PubMed ID: 10911734
[TBL] [Abstract][Full Text] [Related]
22. NAD(P)H and collagen as in vivo quantitative fluorescent biomarkers of epithelial precancerous changes.
Georgakoudi I; Jacobson BC; Müller MG; Sheets EE; Badizadegan K; Carr-Locke DL; Crum CP; Boone CW; Dasari RR; Van Dam J; Feld MS
Cancer Res; 2002 Feb; 62(3):682-7. PubMed ID: 11830520
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous fingerprint and high-wavenumber confocal Raman spectroscopy enhances early detection of cervical precancer in vivo.
Duraipandian S; Zheng W; Ng J; Low JJ; Ilancheran A; Huang Z
Anal Chem; 2012 Jul; 84(14):5913-9. PubMed ID: 22724621
[TBL] [Abstract][Full Text] [Related]
24. Applicability of optical reflectance spectroscopy for detection of precancerous lesions in uterine cervix in vivo.
Hariri Tabrizi S; Farzaneh F; Aghamiri SM
Arch Iran Med; 2014 Sep; 17(9):602-7. PubMed ID: 25204475
[TBL] [Abstract][Full Text] [Related]
25. Fluorescence spectroscopy as a diagnostic tool for detecting cervical pre-cancer.
Chang SK; Pavlova I; Marín NM; Follen M; Richards-Kortum R
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S61-3. PubMed ID: 16419187
[No Abstract] [Full Text] [Related]
26. Understanding the contributions of NADH and collagen to cervical tissue fluorescence spectra: modeling, measurements, and implications.
Drezek R; Sokolov K; Utzinger U; Boiko I; Malpica A; Follen M; Richards-Kortum R
J Biomed Opt; 2001 Oct; 6(4):385-96. PubMed ID: 11728196
[TBL] [Abstract][Full Text] [Related]
27. Optical spectroscopy characteristics can differentiate benign and malignant renal tissues: a potentially useful modality.
Parekh DJ; Lin WC; Herrell SD
J Urol; 2005 Nov; 174(5):1754-8. PubMed ID: 16217277
[TBL] [Abstract][Full Text] [Related]
28. Characterization of LMX-1A as a metastasis suppressor in cervical cancer.
Liu CY; Chao TK; Su PH; Lee HY; Shih YL; Su HY; Chu TY; Yu MH; Lin YW; Lai HC
J Pathol; 2009 Oct; 219(2):222-31. PubMed ID: 19644956
[TBL] [Abstract][Full Text] [Related]
29. In vitro differentiation of epithelial cells from cervical neoplasias resembles in vivo lesions.
Rader JS; Golub TR; Hudson JB; Patel D; Bedell MA; Laimins LA
Oncogene; 1990 Apr; 5(4):571-6. PubMed ID: 1691480
[TBL] [Abstract][Full Text] [Related]
30. Frequency and diagnostic reliability of subvisual morphologic markers for malignancy in the cervical epithelium.
Haroske G; Bergander S; König R
Arch Geschwulstforsch; 1988; 58(3):159-68. PubMed ID: 3415434
[TBL] [Abstract][Full Text] [Related]
31. Development of a fiber optic probe to measure NIR Raman spectra of cervical tissue in vivo.
Mahadevan-Jansen A; Mitchell MF; Ramanujam N; Utzinger U; Richards-Kortum R
Photochem Photobiol; 1998 Sep; 68(3):427-31. PubMed ID: 9747597
[TBL] [Abstract][Full Text] [Related]
32. In vivo and in vitro "markers" of human cervical intraepithelial neoplasia.
Wilbanks GD
Cancer Res; 1976 Jul; 36(7 PT 2):2485-94. PubMed ID: 58720
[TBL] [Abstract][Full Text] [Related]
33. [On the detection of precancer and cancer of the uterine cervix].
Gitman GI
Vopr Onkol; 1969; 15(1):83-4. PubMed ID: 5784524
[No Abstract] [Full Text] [Related]
34. Effect of probe pressure on cervical fluorescence spectroscopy measurements.
Nath A; Rivoire K; Chang S; Cox D; Atkinson EN; Follen M; Richards-Kortum R
J Biomed Opt; 2004; 9(3):523-33. PubMed ID: 15189090
[TBL] [Abstract][Full Text] [Related]
35. Spectroscopic diagnosis and imaging of invisible pre-cancer.
Badizadegan K; Backman V; Boone CW; Crum CP; Dasari RR; Georgakoudi I; Keefe K; Munger K; Shapshay SM; Sheetse EE; Feld MS
Faraday Discuss; 2004; 126():265-79; discussion 303-11. PubMed ID: 14992412
[TBL] [Abstract][Full Text] [Related]
36. A smartphone-based standalone fluorescence spectroscopy tool for cervical precancer diagnosis in clinical conditions.
Shukla S; Deo BS; Vishwakarma C; Mishra S; Ahirwar S; Sah AN; Pandey K; Singh S; Prasad SN; Padhi AK; Pal M; Panigrahi PK; Pradhan A
J Biophotonics; 2024 Jun; 17(6):e202300468. PubMed ID: 38494870
[TBL] [Abstract][Full Text] [Related]
37. Smartphone-based fluorescence spectroscopic device for cervical precancer diagnosis: a random forest classification of in vitro data.
Shukla S; Vishwakarma C; Sah AN; Ahirwar S; Pandey K; Pradhan A
Appl Opt; 2023 Sep; 62(25):6826-6834. PubMed ID: 37706817
[TBL] [Abstract][Full Text] [Related]
38. Fluorescence spectra of blood and urine for cervical cancer detection.
Masilamani V; Alsalhi MS; Vijmasi T; Govindarajan K; Rathan Rai R; Atif M; Prasad S; Aldwayyan AS
J Biomed Opt; 2012 Sep; 17(9):98001-1. PubMed ID: 23085927
[TBL] [Abstract][Full Text] [Related]
39. A statistical model for removing inter-device differences in spectroscopy.
Wang L; Lee JS; Lane P; Atkinson EN; Zuluaga A; Follen M; MacAulay C; Cox DD
Opt Express; 2014 Apr; 22(7):7617-24. PubMed ID: 24718136
[TBL] [Abstract][Full Text] [Related]
40. Design, fabrication and testing of 3D printed smartphone-based device for collection of intrinsic fluorescence from human cervix.
Shukla S; Sah AN; Hatiboruah D; Ahirwar S; Nath P; Pradhan A
Sci Rep; 2022 Jul; 12(1):11192. PubMed ID: 35778460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
